In 347 TAVR patients without an indication for anticoagulation, 3 months of DOAC then SAPT did not significantly reduce leaflet thickening (HALT) at 12 months vs SAPT alone (28.3% vs 32.2%; P=0.54). Death, stroke or major bleeding was higher with DOAC (8.2% vs 2.3%).
RCTn = 352
Jørgensen et al. Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial